β-hydroxybutyrate inhibits malignant phenotypes of prostate cancer cells through β-hydroxybutyrylation of indoleacetamide-N-methyltransferase
Yifan Zhang(Tianjin Medical University Cancer Institute and Hospital), Yunlong Li(First Affiliated Hospital of Zhengzhou University)
Cited by 14
Related Papers
Nanoparticles targeting at methylases with high correlation to N6-methyladenosine-related lncRNA signatures as potential therapy of kidney clear cell carcinoma
|Chinese Chemical Letters|2022|18
Integrating Bulk and Single-Cell RNA-Seq Data to Identify Prognostic Features Related to Activated Dendritic Cells in Clear-Cell Renal-Cell Carcinoma
|International Journal of Molecular Sciences|2024|4